---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-056425"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T16:53:02.588372+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ocuphire promotes Ronil Patel to Chief Business Officer; grants 74K options and 50K RSUs

## Summary
- Ronil Patel, age 40, promoted to Chief Business Officer effective December 1, 2023; previously SVP of Operations and Business Development.
- Base salary set at $350,000, increasing to $400,000 upon meeting certain milestones (e.g., $100M cash balance or strategic term sheet).
- Eligible for annual bonus targeted at 45% of base salary (up from 40%).
- Granted incentive stock option to purchase 74,538 shares and RSU for 49,692 shares, vesting over ~2.5 years.
- Background: 15 years experience; involved in deals over $300M; previously at Point Guard Partners.

## SEC filing metadata
- accession: 0001140361-23-056425
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/0001140361-23-056425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/ef20015996_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-056425
- JSON: https://secwatch.observer/filing/0001140361-23-056425.json
- Plain text: https://secwatch.observer/filing/0001140361-23-056425.txt

## Key facts
- Executive change
  Ronil Patel changed role as Chief Business Officer at Opus Genetics, Inc..
  - Action: promoted
  - Role: Chief Business Officer
  source text: On December 1, 2023, the Board of Directors (the "Board" ) of Ocuphire Pharma, Inc. (the "Company" ) promoted Ronil Patel , age 40, as the Company’s Chief Business Officer, effective as of December 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/0001140361-23-056425-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.